MedTech Terms
    The authoritative reference
    All terms
    Market SegmentsStrategic Landscape

    Women's Health Devices

    Devices addressing reproductive health, pelvic floor, and OB/GYN care.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Women's health spans contraception (IUDs, implants), endometrial ablation, fibroid treatment, pelvic floor and incontinence devices, breast biopsy and imaging (Hologic), and fetal/maternal monitoring.
    What the regulation says
    Regulatory bodies such as the FDA evaluate Women's Health Devices under various classifications depending on their intended use and technology, often involving specific guidance documents related to reproductive health, mammography, or maternal-fetal medicine. The EU MDR (Medical Device Regulation) also classifies these devices based on risk, leading to varying requirements for clinical evidence and conformity assessment. For instance, devices with an aesthetic or non-medical intended purpose fall under MDR, but generally Class IIa or higher; contraceptives are typically Class IIb.

    What this means in practice

    Historically underfunded; FemTech investment surged post-2020. Reimbursement and patient pay-mix vary dramatically by sub-segment.

    Examples

    • A company developing an AI-powered mammography device must adhere to FDA guidance on Medical Devices Containing Artificial Intelligence or Machine Learning-Based Software, in addition to specific mammography regulations.
    • A manufacturer of an intravaginal ring for contraception must conduct biocompatibility testing per ISO 10993 and demonstrate efficacy and safety through rigorous clinical trials, as per the device classification, e.g., Class IIb under EU MDR.
    • A startup creating a wearable sensor for fetal monitoring needs to consider data privacy regulations like HIPAA in the US or GDPR in the EU, alongside performance standards for medical electrical equipment like IEC 60601-1.
    Common pitfalls
    • •A common pitfall is failing to account for sex-specific physiological differences in device design and clinical trial enrollment, potentially leading to suboptimal efficacy or safety for women.
    • •Another mistake is overlooking the unique cybersecurity and privacy considerations for sensitive health data related to reproductive health or personal wellness devices.
    • •Companies sometimes misinterpret reimbursement codes, leading to commercialization delays or market access issues.
    • •Inaccurate labeling or promotional claims that overstate benefits specific to women's health can lead to regulatory scrutiny and enforcement actions.

    Frequently asked questions

    Device classification for Women's Health Devices depends on their intended use, risk profile, and mechanism of action, as defined by regulations like FDA 21 CFR Part 860 or EU MDR Annex VIII. This classification dictates the regulatory pathway, including premarket submission requirements and postmarket surveillance obligations.
    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    ACOG·1AdvaMed·1MedTech Europe·1
    1. 1
      ACOG
      Verified
      ACOGacog.org
    2. 2
      AdvaMed - Industry Reports
      Verified
      AdvaMedadvamed.org
    3. 3
      MedTech Europe - Facts & Figures
      Verified
      MedTech Europemedtecheurope.org

    Inline markers like [1] jump to the matching reference above.